StellaLife VEGA Oral Care Gel — Class II drug recall D-0889-2023
Terminated recall by Homeocare Laboratories, Inc., reported 2023-07-05, distributed nationwide. cGMP deviations
| Recall number | D-0889-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Homeocare Laboratories, Inc., Yonkers, NY, United States |
| Recall initiated | 2023-06-05 |
| Classified | 2023-06-26 |
| Reported by FDA | 2023-07-05 |
| Terminated | 2024-09-16 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 69685-0102-02 |
| Lot numbers | 2334, 2363, 2365, JAN-24, NOV-23, SEP-23 |
Product
StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-102-02
Reason for recall
cGMP deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0889-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.